目的观察肝动脉化疗栓塞与中西结合综合治疗原发性肝癌的临床效果。方法将邢台市人民医院2009年1月至2009年12月收治的100例原发性肝癌患者随机分为观察组和对照组各50例,对照组给予肝动脉化疗栓塞治疗,观察组在对照组治疗基础上给予中西结合综合治疗。结果观察组患者总有效率为82.0%,明显的高于对照组的62.0%,差异有统计学意义(P<0.05);两组患者治疗1年后生存率比较无明显差异,观察组治疗2年、3年的生存率明显高于对照组(P<0.05);观察组生活质量提高稳定率为94.0%,明显高于对照组的68.0%,两组比较差异统计学有意义(P<0.05)。结论对于原发性肝癌患者给予肝动脉化疗栓塞与中西结合综合治疗具有较好的临床效果,且能提高患者的生活质量。 Objective To observe the clinical effect of transcatheter arterial chemoembolization combined with Chinese and western medicine in the treatment of primary liver cancer. Methods 100 patients with primary liver cancer who were treated in Xingtai People’s Hospital from January 2009 to December 2009 were randomly divided into observation group and control group, 50 cases in each group. The control group was treated with chemoembolization of hepatic artery. On the basis of treatment combined treatment of Chinese and Western. Results The total effective rate of observation group was 82.0%, significantly higher than that of control group (62.0%), the difference was statistically significant (P <0.05). There was no significant difference in survival rate between two groups after treatment for one year. The treatment group 2 Year and 3-year survival rates were significantly higher than those in the control group (P <0.05). The improvement of the quality of life in the observation group was 94.0%, which was significantly higher than that in the control group (68.0%), with significant difference between the two groups (P <0.05 ). Conclusion Hepatic arterial chemoembolization combined with integrated traditional Chinese and western medicine in patients with primary liver cancer has good clinical effect and can improve the quality of life of patients.